Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.09 | N/A |
| PEG Ratio (TTM) | 16.92 | N/A |
| P/S Ratio (TTM) | 1.52 | N/A |
| P/B Ratio (TTM) | 2.59 | N/A |
| P/FCF Ratio (TTM) | 6.01 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.16 | N/A |
| Price to 5YR AVG FCF Ratio | 4.53 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.30% | N/A |
| ROE (TTM) | 15.31% | N/A |
| Net Profit Margin (TTM) | 9.02% | N/A |
| ROIC 5YR AVG | 37.52% | N/A |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 260.90% | 312.19% | 171.31% |
| Revenue | 14.04% | 41.54% | 23.32% |
| Net Income | 274.80% | 341.74% | 186.88% |
| Cash Flow | 9.51% | 154.22% | 78.51% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.77 | N/A |
| Quick Ratio (TTM) | 5.77 | N/A |
| D/E Ratio (TTM) | 1.71 | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.61 | N/A |
| LTL to 5YR AVG FCF | 2.49 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.95% | N/A |